An experimental coronavirus vaccine being developed by AstraZeneca and Oxford university was safe and produced an immune response in early-stage clinical trials, data showed. | Covid19SA CovidVaccine
London - An experimental coronavirus vaccine being developed by AstraZeneca and Oxford university was safe and produced an immune response in early-stage clinical trials, data showed on Monday, keeping alive the hope it could be in use by the end of the year.
More than 150 possible vaccines are in various stages of development with U.S. drugmaker Pfizer and China's CanSino Biologics also reporting positive responses for their candidates on Monday. UK Prime Minister Boris Johnson, whose government has helped to fund the project, hailed the results as "very positive news.""There is still much work to be done before we can confirm if our vaccine will help manage the Covid-19 pandemic," vaccine developer Sarah Gilbert said.
AstraZeneca shares surged 10%, but then gave up most of those gains, to trade 1.2% stronger on the day.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Oxford Covid-19 vaccine human trial shows promiseAstraZeneca has signed agreements with governments around the world, which would see the vaccine be distributed without attempting to profit from it, should it prove effective and gain regulatory approval.
Read more »
First human trial of Oxford COVID-19 vaccine shows promiseMore than 150 possible vaccines are in various stages of development with U.S. drugmaker Pfizer and China's CanSino Biologics.
Read more »
Coronavirus: Oxford-AstraZeneca Covid vaccine study shows dual immune actionA coronavirus vaccine the University of Oxford is developing with AstraZeneca Plc showed promising results in early human testing, a sign of progress in the high-stakes pursuit of a shot to defeat the pathogen.
Read more »
Cubans celebrate no local transmission of COVID-19 for first time in 4 monthsFrancisco Duran, head of epidemiology at the Ministry of Public Health, and who has updated the country daily on the pandemic, took off his mask during the national broadcast for only the second time deliver the good news.
Read more »
COVID-19: EU leaders show first signs of compromise on stimulus planBRUSSELS, July 20 (Reuters) - Signs emerged that leaders of northern European Union countries were willing to compromise on a 1.8 trillion euro ($2 trillion) coronavirus stimulus plan on Monday as talks in Brussels extended to a fourth day.
Read more »